Vaccine keeps advanced kidney cancer from recurring

Health Rounds: Vaccine keeps advanced kidney cancer from recurring
Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still cancer-free years later in a small early-stage trial, researchers reported in Nature.
Kidney Cancer Vaccine Shows Promise in Early Trial
In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated robust immune response, according to findings of a new study led by HMS researchers at Dana-Farber Cancer Institute.
Personalized cancer vaccine shows potential in kidney cancer
In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.
Breakthrough personalized vaccine shows promising results in kidney cancer trial
Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine.
Experimental vaccine seems to battle advanced kidney cancers
A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, researchers report.
Three Years After Experimental Vaccine, These Patients Are Still Cancer-Free
Scientists at the Dana-Farber Cancer Institute and elsewhere developed the vaccine, which is designed to prevent advanced cases of kidney cancer from returning. Since the trial patients received the vaccine roughly three years ago,
Immunogenic Cancer Vaccine Targets Key Mutations in Kidney Cancer
Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell carcinoma (RCC) and can target key driver mutations and induce antitumor immunity, according to a study published online Feb.
Boston researchers make progress in kidney cancer vaccine
Doctors at Dana-Farber say this personalized vaccine can be given after surgery to remove a tumor and train the body’s immune system to eliminate tumor cells.
Personalized vaccines halt kidney cancer after encouraging phase 1 trial
In a nutshell Researchers developed personalized cancer vaccines for nine high-risk kidney cancer patients, with all participants remaining cancer-free after nearly three years of follow-up – a significant advancement for a cancer type that traditionally has limited treatment options.
The American Journal of Managed Care2d
Promising Cancer Vaccine Boosts Hope for Stage III and IV Kidney Cancer
All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...
MedPage Today7d
NBA Hall of Famer Dwyane Wade Reveals Kidney Cancer Diagnosis
Basketball Hall of Famer Dwyane Wade talked for the first time yesterday about his surgery for kidney cancer in December 2023.
Dwyane Wade reveals kidney cancer diagnosis, surgery
Former NBA All-Star and champion Dwyane Wade on Thursday announced he had 40% of his right kidney removed along with a ...